{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "Molecular diagnosis",
      "RT-qPCR",
      "SARS-CoV-2"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35379178",
  "DateCompleted": {
    "Year": "2022",
    "Month": "04",
    "Day": "06"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "04",
    "Day": "08"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "04",
        "Day": "04"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "329",
      "10.1186/s12879-022-07319-0"
    ],
    "Journal": {
      "ISSN": "1471-2334",
      "JournalIssue": {
        "Volume": "22",
        "Issue": "1",
        "PubDate": {
          "Year": "2022",
          "Month": "Apr",
          "Day": "04"
        }
      },
      "Title": "BMC infectious diseases",
      "ISOAbbreviation": "BMC Infect Dis"
    },
    "ArticleTitle": "Evaluation of the SMARTCHEK Genesystem RT-qPCR assay for the detection of SARS-CoV-2 in clinical samples.",
    "Pagination": {
      "StartPage": "329",
      "MedlinePgn": "329"
    },
    "Abstract": {
      "AbstractText": [
        "The COVID-19 pandemic remains the main public health problem, due to the quick and easy dissemination of the causal agent, SARS-CoV-2 virus, around the world. Since the beginning of the pandemic, an opportune laboratory diagnosis has been critical to respond this emergency, and RT-qPCR has been used as reference molecular tests for detection of SARS-CoV-2.",
        "In this study, we performed the evaluation of a RT-qPCR SMARTCHEK platform (SMARTCHEK, Genesystem) for SARS-CoV-2 detection based on the amplification of RdRp and N gene markers. The platform was evaluated with nasopharyngeal swab samples corresponding to 360 suspected cases of COVID-19 which were remitted to Instituto Nacional de Salud in Peru. This quick method was compared with conventional RT-qPCR as gold standard.",
        "The RT-qPCR SMARTCHEK showed a 98.1% sensitivity (CI: 93.3-99.8%), a 98.8% specificity (CI: 96.6-99.8%), a 97.2% positive predictive value (CI: 92-99.4%) and a 99.2% negative predictive value (CI: 97.2-99.9%). The assay demonstrated a strong agreement between the RT-qPCR SMARTCHEK and conventional RT-qPCR (kappa value\u2009\u2265\u20090.966).",
        "The RT-qPCR SMARTCHEK is a platform that gives reliable and fast results, with high sensitivity and specificity for the detection of SARS-CoV-2, and it will be considered a suitable alternative to COVID-19 diagnosis in low-resource settings."
      ],
      "CopyrightInformation": "\u00a9 2022. The Author(s)."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud, Lima, Peru."
          },
          {
            "Identifier": [],
            "Affiliation": "Escuela Profesional de Medicina Humana, Universidad Privada San Juan Bautista, Lima, Peru."
          }
        ],
        "LastName": "Flores-Le\u00f3n",
        "ForeName": "Diana",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud, Lima, Peru."
          }
        ],
        "LastName": "Quino",
        "ForeName": "Willi",
        "Initials": "W"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud, Lima, Peru."
          }
        ],
        "LastName": "C\u00faneo",
        "ForeName": "Alejandra E",
        "Initials": "AE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud, Lima, Peru."
          }
        ],
        "LastName": "Caro-Castro",
        "ForeName": "Junior",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud, Lima, Peru."
          }
        ],
        "LastName": "Cucho-Meza",
        "ForeName": "Evans",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud, Lima, Peru. rgavilan@ins.gob.pe."
          },
          {
            "Identifier": [],
            "Affiliation": "Escuela Profesional de Medicina Humana, Universidad Privada San Juan Bautista, Lima, Peru. rgavilan@ins.gob.pe."
          }
        ],
        "LastName": "Gavilan",
        "ForeName": "Ronnie G",
        "Initials": "RG"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "BMC Infect Dis",
    "NlmUniqueID": "100968551",
    "ISSNLinking": "1471-2334"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "diagnosis"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Testing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sensitivity and Specificity"
    }
  ],
  "CoiStatement": "The authors declare that they have no competing interests."
}